Surgical treatment of pheochromocytoma

This review article contains a summary of modern aspects of preoperative preparation, surgical treatment, and follow-up of patients with adrenal pheochromocytomas. The main component of preoperative preparation is the use of alpha-blockers. The need to prescribe them to all patients is increasingly disputed, especially for patients without severe hypertension. An increasing number of publications demonstrate positive results of treatment without the use of alpha-blockers, advocating an individual approach and the use of the drug according to certain indications. Minimally invasive endoscopic techniques of adrenalectomy have become widespread in surgical treatment. They are represented by laparoscopic and retroperitonescopic technic, including using their single-port modifications. The earliest possible intersection of the central vein in the past was considered the most important aspect of adrenalectomy for pheochromocytoma, currently, due to the development of surgical techniques and anesthesiological manuals, this has ceased to be a mandatory rule of successful surgery. Despite the significant influence of the intersection of this vessel on intraoperative hemodynamics, surgical tactics with its later intersection have their own justifications and do not lead to a deterioration in treatment results. The standard volume of surgical intervention for pheochromocytomas is total adrenalectomy, however, in the presence of hereditary syndromes, such as multiple endocrine neoplasia type 2 syndrome, neurofibomatosis type 1, von Hippel-Lindau syndrome, it is possible to perform cortical-sparing adrenalectomy.

1. Groeben H, Walz MK, Nottebaum BJ, et al. International multicentre review of perioperative management and outcome for catecholamine-producing tumours. Br J Surg. 2020;107(2):e170-e178. doi: https://doi.org/10.1002/bjs.11378

2. Troshina EA, Beltsevich DG, Yukina MY. Laboratory diagnostics of pheochromocytoma. Problems of Endocrinology. 2010;56(4):39-43 (In Russ.). doi: https://doi.org/10.14341/probl201056439-43

3. Lenders JWM, Duh Q-Y, Eisenhofer G, et al. Pheochromocytoma and paraganglioma: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915-1942. doi: https://doi.org/10.1210/jc.2014-1498

4. Melnichenko GA, Troshina EA, Beltsevich DG. Russian Association of Endocrinologist clinical practice guidelines for diagnosis and treatment of pheochromocytoma and paraganglioma. Endocrine Surgery. 2015;9(3):15-33. (In Russ.). doi: https://doi.org/10.14341/serg2015315-33

5. Alekseev MA, Kuleshov OV, Fedorov EA, et al. Evolution of perioperative management of catecholamine-producing tumors. Russian Journal of Anesthesiology and Reanimatology. 2022;(4):85-91. (In Russ.). doi: https://doi.org/10.17116/anaesthesiology202204185

6. Bihain F, Nomine-Criqui C, Guerci P. et al. Management of patients with treatment of pheochromocytoma: A critical appraisal. Cancers. 2022;14(16):3845. doi: https://doi.org/10.3390/cancers14163845

7. Neumann HPH, Young WF, Eng C. Pheochromocytoma and paraganglioma. N Engl J Med. 2019;381(6):552-565. doi: https://doi.org/10.1056/NEJMra1806651

8. Groeben H, Nottebaum BJ, Alesina PF, et al. Perioperative α-receptor blockade in phaeochromocytoma surgery: an observational case series. Br J Anaesth. 2017;118(2):182-189. doi: https://doi.org/10.1093/bja/aew392

9. Buisset C, Guerin C, Cungi P-J, et al. Pheochromocytoma surgery without systematic preoperative pharmacological preparation: insights from a referral tertiary center experience. Surg Endosc. 2021;35(2):728-735. doi: https://doi.org/10.1007/s00464-020-07439-1

10. Shao Y, Chen R, Shen Z, et al. Preoperative alpha blockade for normotensive pheochromocytoma. J Hypertens. 2011;29(12):2429-2432. doi: https://doi.org/10.1097/HJH.0b013e32834d24d9

11. Lentschener C, Gaujoux S, Thillois JM, et al. Increased arterial pressure is not predictive of haemodynamic instability in patients undergoing adrenalectomy for phaeochromocytoma. Acta Anaesthesiol Scand. 2009;53(4):522-527. doi: https://doi.org/10.1111/j.1399-6576.2008.01894.x

12. Kasahara T, Nishiyama T, Takahashi K. Laparoscopic adrenalectomy for pheochromocytoma: evaluation of experience and strategy at a single institute. BJU Int. 2009;103(2):218-222. doi: https://doi.org/10.1111/j.1464-410X.2008.07894.x

13. Castinetti F, De Freminville J-B, Guerin C, et al. Controversies about the systematic preoperative pharmacological treatment before pheochromocytoma or paraganglioma surgery. Eur J Endocrinol. 2022;186(5):D17-D24. doi: https://doi.org/10.1530/EJE-21-0692

14. Lenders JWM, Kerstens MN, Amar L, et al. Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. J Hypertens. 2020;38(8):1443-1456. doi: https://doi.org/10.1097/HJH.0000000000002438

15. Plouin PF, Amar L, Dekkers OM, et al. European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma. Eur J Endocrinol. 2016;174(5):G1-G10. doi: https://doi.org/10.1530/EJE-16-0033

16. Challis BG, Casey RT, Simpson HL, Gurnell M. Is there an optimal preoperative management strategy for phaeochromocytoma/paraganglioma? Clin Endocrinol (Oxf). 2017;86(2):163-167. doi: https://doi.org/10.1111/cen.13252

17. Sibal L, Jovanovic A, Agarwal SC, et al. Phaeochromocytomas presenting as acute crises after beta blockade therapy. Clin Endocrinol (Oxf). 2006;65(2):186-190. doi: https://doi.org/10.1111/j.1365-2265.2006.02571.x

18. Kudva YC, Sawka AM, Young WF. The laboratory diagnosis of adrenal pheochromocytoma: The mayo clinic experience. J Clin Endocrinol Metab. 2003;88(10):4533-4539. doi: https://doi.org/10.1210/jc.2003-030720

19. Zhu W, Wang S, Du G, et al. Comparison of retroperitoneal laparoscopic versus open adrenalectomy for large pheochromocytoma: a single-center retrospective study. World J Surg Oncol. 2019;17(1):111. doi: https://doi.org/10.1186/s12957-019-1649-x

20. Iglesias P, Santacruz E, García-Sancho P, et al. Pheochromocytoma: A three-decade clinical experience in a multicenter study. Rev Clínica Española (English Ed. 2021;221(1):18-25. doi: https://doi.org/10.1016/j.rceng.2019.12.011

21. Rebrova DV, Rusakov VF, Fedorov EA, et al. Rare case of pheochromocytoma with calcitonin hypersecretion. Pharmateca. 2021;28(4):90-98. (In Russ.). doi: https://doi.org/10.18565/pharmateca.2021.4.90-98

22. Bai S, Yao Z, Zhu X, et al. Comparison of transperitoneal laparoscopic versus open adrenalectomy for large pheochromocytoma: A retrospective propensity score-matched cohort study. Int J Surg. 2019;61(1):26-32. doi: https://doi.org/10.1016/j.ijsu.2018.11.018

23. Bai S, Yao Z, Zhu X, et al. Comparison of transperitoneal laparoscopic versus open adrenalectomy for large pheochromocytoma: A retrospective propensity score-matched cohort study. Int J Surg. 2019;61(1):26-32. doi: https://doi.org/10.1016/j.ejso.2020.02.009

24. Conzo G, Tartaglia E, Gambardella C, et al. Minimally invasive approach for adrenal lesions: Systematic review of laparoscopic versus retroperitoneoscopic adrenalectomy and assessment of risk factors for complications. Int J Surg. 2016;28(1):S118-S123. doi: https://doi.org/10.1016/j.ijsu.2015.12.042

25. Prudhomme T, Roumiguié M, Gas J, et al. Comparison between retroperitoneal and transperitoneal laparoscopic adrenalectomy: Are both equally safe? J Visc Surg. 2021;158(3):204-210. doi: https://doi.org/10.1016/j.jviscsurg.2020.07.009

26. Barczyński M, Konturek A, Nowak W. Randomized clinical trial of posterior retroperitoneoscopic adrenalectomy versus lateral transperitoneal laparoscopic adrenalectomy with a 5-year follow-up. Ann Surg. 2014;260(5):740-748. doi: https://doi.org/10.1097/SLA.0000000000000982

27. Dickson PV, Alex GC, Grubbs EG, et al. Posterior retroperitoneoscopic adrenalectomy is a safe and effective alternative to transabdominal laparoscopic adrenalectomy for pheochromocytoma. Surgery. 2011;150(3):452-458. doi: https://doi.org/10.1016/j.surg.2011.07.004

28. Gavriilidis P, Camenzuli C, Paspala A, et al. Posterior Retroperitoneoscopic Versus Laparoscopic Transperitoneal Adrenalectomy: A Systematic Review by an Updated Meta-Analysis. World J Surg. 2021;45(1):168-179. doi: https://doi.org/10.1007/s00268-020-05759-w

29. Chen F, Adhami M, Tan M, et al. Hypotension in posterior retroperitoneoscopic versus transperitoneal laparoscopic adrenalectomy. J Surg Res. 2022;275(1):87-95. doi: https://doi.org/10.1016/j.jss.2022.01.013

30. Vrielink OM, Engelsman AF, Hemmer PHJ, et al. Multicentre study evaluating the surgical learning curve for posterior retroperitoneoscopic adrenalectomy. Br J Surg. 2018;105(5):544-551. doi: https://doi.org/10.1002/bjs.10740

31. Dickson P V., Jimenez C, Chisholm GB, et al. Posterior retroperitoneoscopic adrenalectomy: A contemporary American experience. J Am Coll Surg. 2011;212(4):659-665. doi: https://doi.org/10.1016/j.jamcollsurg.2010.12.023

32. Walz MK, Groeben H, Alesina PF. Single-Access Retroperitoneoscopic Adrenalectomy (SARA) Versus Conventional Retroperitoneoscopic Adrenalectomy (CORA): A case–control study. World J Surg. 2010;34(6):1386-1390. doi: https://doi.org/10.1007/s00268-010-0494-4

33. Chen W, Xu Z-B, Xu L, Guo J-M. Comparison of cosmetic effect and pain reduction outcomes of modified mini-laparoscopy versus laparoendoscopic single-site surgery for adrenalectomy. J Laparoendosc Adv Surg Tech. 2019;29(12):1544-1548. doi: https://doi.org/10.1089/lap.2019.0554

34. Jia J, Yang Z, Teng Z, Han Z. Efficacy and safety of laparoendoscopic single-site adrenalectomy versus conventional laparoscopic adrenalectomy: an updated systematic review and meta-analysis. Videosurgery Other Miniinvasive Tech. 2022;17(1):20-34. doi: https://doi.org/10.5114/wiitm.2021.110446

35. Agcaoglu O, Sengun B, Senol K, et al. Comparison of technical details and short-term outcomes of single-incision versus multiport laparoscopic adrenalectomy. Surg Laparosc Endosc Percutan Tech. 2019;29(1):49-52. doi: https://doi.org/10.1097/SLE.0000000000000596

36. Matsuda T, Murota T, Oguchi N, et al. Laparoscopic adrenalectomy for pheochromocytoma: a literature review. Biomedicine and pharmacotherapy. Biomed Pharmacother. 2002;56(1):132-138. doi: https://doi.org/10.1016/S0753-3322(02)00231-7

37. Alesina PF. Retroperitoneal adrenalectomy — learning curve, practical tips and tricks, what limits its wider uptake. Gland Surgery. 2019;8(1)36-40. doi: https://doi.org/10.21037/gs.2019.03.11

38. Walz MK, Alesina PF, Wenger FA, et al. Posterior retroperitoneoscopic adrenalectomy — results of 560 procedures in 520 patients. Surgery. 2006;140(6):943-950. doi: https://doi.org/10.1016/j.surg.2006.07.039

39. Zhang X, Fu B, Lang B, et al. Technique of anatomical retroperitoneoscopic adrenalectomy with report of 800 cases. The Journal of urology. 2007;177(4):1254-1257. doi:10.1016/j.juro.2006.11.098

40. Wu G, Zhang B, Yu C, et al. Effect of early adrenal vein ligation on blood pressure and catecholeamine fluctuation during laparoscopic adrenalectomy for pheochromocytoma. Urology. 2013;82(3):606-611. doi: https://doi.org/10.1016/j.urology.2013.05.011

41. Zhang X, Lang B, Ouyang JZ, et al. Retroperitoneoscopic adrenalectomy without previous control of adrenal vein is feasible and safe for pheochromocytoma. Urology. 2007;69(5):849-853. doi: https://doi.org/10.1016/j.urology.2007.01.078

42. Kahramangil B, Montorfano L, Gutierrez D, et al. Biochemical assessment of adrenal insufficiency after adrenalectomy for non-cortisol secreting tumors: clinical correlation and recommendations. Surg Endosc. 2022;36(10):7638-7646. doi: https://doi.org/10.1007/s00464-022-09232-8

43. Mitchell J, Barbosa G, Tsinberg M, et al. Unrecognized adrenal insufficiency in patients undergoing laparoscopic adrenalectomy. Surg Endosc. 2009;23(2):248-254. doi: https://doi.org/10.1007/s00464-008-0189-1

44. Perysinakis I, Aggeli C, Kaltsas G, Zografos GN. Adrenal-sparing surgery: current concepts on a theme from the past. Hormones. 2020;19(3):317-327. doi: https://doi.org/10.1007/s42000-020-00202-0

45. Rebrova DV, Vorokhobina NV, Imyanitov EN, et al. Clinical and laboratory features of hereditary pheochromocytoma and paraganglioma. Problems of Endocrinology. 2022;68(1):8-17. (In Russ.). doi: https://doi.org/10.14341/probl12834

46. Zawadzka K, Tylec P, Małłczak P, et al. Cortical-sparing adrenalectomy for bilateral pheochromocytoma - is it a game worth the candle? Systematic review with meta-analysis comparing total vs partial adrenalectomy in bilateral pheochromocytoma. Endocr Abstr. 2022;23(2):248-254. doi: https://doi.org/10.1530/endoabs.81.P520

47. Castinetti F, Taieb D, Henry JF, et al. Management of endocrine disease: Outcome of adrenal sparing surgery in heritable pheochromocytoma. Eur J Endocrinol. 2016;174(1):R9-R18. doi: https://doi.org/10.1530/EJE-15-0549

48. Walz MK, Peitgen K, Diesing D, et al. Partial versus total adrenalectomy by the posterior retroperitoneoscopic approach: early and long-term results of 325 consecutive procedures in primary adrenal neoplasias. World J Surg. 2004;28(12):1323-1329. doi: https://doi.org/10.1007/s00268-004-7667-y

49. Rossitti HM, Söderkvist P, Gimm O. Extent of surgery for phaeochromocytomas in the genomic era. Br J Surg. 2018;105(2):e84-e98. doi: https://doi.org/10.1002/bjs.10744

50. Neumann HPH, Tsoy U, Bancos I, et al. Comparison of pheochromocytoma-specific morbidity and mortality among adults with bilateral pheochromocytomas undergoing total adrenalectomy vs cortical-sparing adrenalectomy. JAMA Netw Open. 2019;2(8):e198898. doi: https://doi.org/10.1001/jamanetworkopen.2019.8898

51. Brauckhoff M, Gimm O, Thanh PN, et al. Critical size of residual adrenal tissue and recovery from impaired early postoperative adrenocortical function after subtotal bilateral adrenalectomy. Surgery. 2003;134(6):1020-1027. doi: https://doi.org/10.1016/j.surg.2003.08.005

52. Aygun N. Pheochromocytoma and paraganglioma: from treatment to follow-up. SiSli Etfal Hastan Tip Bul / Med Bull Sisli Hosp. 2020;2(8):e198898. doi: https://doi.org/10.14744/SEMB.2020.58998